Novo Nordisk Partners with Anthropic to Speed Up Drug Development Using Claude

Dr_Singularity · x · 2026-09-17

Novo Nordisk, the company behind Ozempic, is partnering with Anthropic to accelerate drug development using Claude. The author frames it as bio/acc in action: adding frontier AI to every stage of science and scaling it with autonomous agents could make drug development thousands of times faster.

Related event: Novo Nordisk partners with Anthropic to accelerate drug R&D with Claude Science(6 posts)→

Original post →

More from Companies & People

Companies & People channel →